JP2017528465A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017528465A5 JP2017528465A5 JP2017513409A JP2017513409A JP2017528465A5 JP 2017528465 A5 JP2017528465 A5 JP 2017528465A5 JP 2017513409 A JP2017513409 A JP 2017513409A JP 2017513409 A JP2017513409 A JP 2017513409A JP 2017528465 A5 JP2017528465 A5 JP 2017528465A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- composition
- patient
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087382A JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462048512P | 2014-09-10 | 2014-09-10 | |
| US62/048,512 | 2014-09-10 | ||
| PCT/IB2015/056871 WO2016038538A1 (en) | 2014-09-10 | 2015-09-08 | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087382A Division JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017528465A JP2017528465A (ja) | 2017-09-28 |
| JP2017528465A5 true JP2017528465A5 (enExample) | 2018-10-04 |
Family
ID=54186247
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017513409A Withdrawn JP2017528465A (ja) | 2014-09-10 | 2015-09-08 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ−１７アンタゴニストの使用 |
| JP2021087382A Active JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A Active JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A Pending JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087382A Active JP7288927B2 (ja) | 2014-09-10 | 2021-05-25 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2023087736A Active JP7591092B2 (ja) | 2014-09-10 | 2023-05-29 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
| JP2024199491A Pending JP2025024104A (ja) | 2014-09-10 | 2024-11-15 | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US11278618B2 (enExample) |
| EP (2) | EP4406969A3 (enExample) |
| JP (4) | JP2017528465A (enExample) |
| KR (2) | KR20230170796A (enExample) |
| CN (4) | CN113069542A (enExample) |
| AU (2) | AU2015313827C1 (enExample) |
| BR (1) | BR112017003332A2 (enExample) |
| CA (1) | CA2960754A1 (enExample) |
| DK (1) | DK3191120T3 (enExample) |
| ES (1) | ES2981697T3 (enExample) |
| FI (1) | FI3191120T3 (enExample) |
| HR (1) | HRP20240921T1 (enExample) |
| HU (1) | HUE067081T2 (enExample) |
| LT (1) | LT3191120T (enExample) |
| MX (1) | MX2017003216A (enExample) |
| PL (1) | PL3191120T3 (enExample) |
| PT (1) | PT3191120T (enExample) |
| RS (1) | RS65851B1 (enExample) |
| RU (1) | RU2697383C2 (enExample) |
| SI (1) | SI3191120T1 (enExample) |
| SM (1) | SMT202400285T1 (enExample) |
| WO (1) | WO2016038538A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11278618B2 (en) | 2014-09-10 | 2022-03-22 | Novartis Ag | Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients |
| MY207225A (en) | 2015-10-27 | 2025-02-06 | UCB Biopharma SRL | Methods of treatment using anti-il-17a/f antibodies |
| TW201842933A (zh) * | 2017-05-05 | 2018-12-16 | 瑞士商諾華公司 | 使用il-17拮抗劑選擇性治療氣喘的方法 |
| CN111032691A (zh) * | 2017-08-23 | 2020-04-17 | 伊莱利利公司 | 生殖器银屑病的治疗 |
| WO2019087133A1 (en) * | 2017-11-02 | 2019-05-09 | Novartis Ag | Method of treating tendinopathy using interleukin-17 (il-17) |
| JP2022536088A (ja) * | 2019-06-04 | 2022-08-12 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ２３特異的抗体で乾癬性関節炎を治療する安全かつ有効な方法 |
| KR102604172B1 (ko) | 2019-12-05 | 2023-11-22 | 아주대학교산학협력단 | 펩타이드 또는 이의 혼합물을 유효성분으로 함유하는 베체트병 또는 류마티스 관절염 예방 또는 치료용 약학조성물 |
| KR102394378B1 (ko) | 2020-10-14 | 2022-05-03 | 한림대학교 산학협력단 | 피부 각질세포에서의 아릴탄화수소 수용체 억제자(AhRR) 과발현 방법 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0417487D0 (en) * | 2004-08-05 | 2004-09-08 | Novartis Ag | Organic compound |
| GB0425569D0 (en) | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Biological products |
| CN101326195B9 (zh) | 2005-12-13 | 2022-11-11 | 伊莱利利公司 | 抗il-17抗体 |
| CN101374864A (zh) | 2006-01-31 | 2009-02-25 | 诺瓦提斯公司 | 用于靶向癌症的il-17拮抗性抗体 |
| GB0612928D0 (en) | 2006-06-29 | 2006-08-09 | Ucb Sa | Biological products |
| US7833527B2 (en) | 2006-10-02 | 2010-11-16 | Amgen Inc. | Methods of treating psoriasis using IL-17 Receptor A antibodies |
| JP5237366B2 (ja) | 2007-06-20 | 2013-07-17 | メルク・シャープ・アンド・ドーム・コーポレーション | 炎症性関節疾患に対する抗ｉｌ−１７ａ治療のための関節破壊のバイオマーカー |
| US7856118B2 (en) | 2007-07-20 | 2010-12-21 | The Procter & Gamble Company | Methods for recommending a personal care product and tools therefor |
| KR101318549B1 (ko) | 2008-09-29 | 2013-10-16 | 로슈 글리카트 아게 | 인간 ｉｌ17 에 대한 항체 및 이의 용도 |
| RU2665954C1 (ru) * | 2010-10-08 | 2018-09-05 | Новартис Аг | Способы лечения псориаза с использованием антагонистов il-17 |
| TWI616204B (zh) * | 2010-11-05 | 2018-03-01 | 諾華公司 | Ｉｌ-１７抗體用於製備治療牛皮癬性關節炎之藥物之用途 |
| WO2012082573A1 (en) | 2010-12-13 | 2012-06-21 | Novartis Ag | Predictive methods and methods of treating arthritis using il-17 antagonists |
| KR20140097178A (ko) * | 2011-11-21 | 2014-08-06 | 노파르티스 아게 | IL-17 길항제 및 건선성 관절염 (PsA) 반응 또는 비-반응 대립유전자를 이용하여 PsA를 치료하는 방법 |
| CN103936854B (zh) * | 2014-04-30 | 2016-08-17 | 北京精益泰翔技术发展有限公司 | 抗il-17a单克隆抗体及其制备与应用 |
| US11278618B2 (en) * | 2014-09-10 | 2022-03-22 | Novartis Ag | Use of IL-17 antagonists to inhibit the progression of structural damage in psoriatic arthritis patients |
-
2015
- 2015-09-08 US US15/508,441 patent/US11278618B2/en active Active
- 2015-09-08 KR KR1020237041277A patent/KR20230170796A/ko not_active Ceased
- 2015-09-08 EP EP24169328.2A patent/EP4406969A3/en active Pending
- 2015-09-08 EP EP15767597.6A patent/EP3191120B1/en active Active
- 2015-09-08 SI SI201532020T patent/SI3191120T1/sl unknown
- 2015-09-08 WO PCT/IB2015/056871 patent/WO2016038538A1/en not_active Ceased
- 2015-09-08 CN CN202110368292.4A patent/CN113069542A/zh active Pending
- 2015-09-08 JP JP2017513409A patent/JP2017528465A/ja not_active Withdrawn
- 2015-09-08 HU HUE15767597A patent/HUE067081T2/hu unknown
- 2015-09-08 HR HRP20240921TT patent/HRP20240921T1/hr unknown
- 2015-09-08 BR BR112017003332A patent/BR112017003332A2/pt not_active Application Discontinuation
- 2015-09-08 KR KR1020177006313A patent/KR20170045240A/ko not_active Ceased
- 2015-09-08 RS RS20240773A patent/RS65851B1/sr unknown
- 2015-09-08 CN CN202210788000.7A patent/CN115957326A/zh active Pending
- 2015-09-08 CN CN201580047920.1A patent/CN107073110A/zh active Pending
- 2015-09-08 MX MX2017003216A patent/MX2017003216A/es unknown
- 2015-09-08 ES ES15767597T patent/ES2981697T3/es active Active
- 2015-09-08 PL PL15767597.6T patent/PL3191120T3/pl unknown
- 2015-09-08 FI FIEP15767597.6T patent/FI3191120T3/fi active
- 2015-09-08 LT LTEPPCT/IB2015/056871T patent/LT3191120T/lt unknown
- 2015-09-08 SM SM20240285T patent/SMT202400285T1/it unknown
- 2015-09-08 PT PT157675976T patent/PT3191120T/pt unknown
- 2015-09-08 CA CA2960754A patent/CA2960754A1/en active Pending
- 2015-09-08 CN CN202210786909.9A patent/CN115944734A/zh active Pending
- 2015-09-08 DK DK15767597.6T patent/DK3191120T3/da active
- 2015-09-08 RU RU2017107501A patent/RU2697383C2/ru active
- 2015-09-08 AU AU2015313827A patent/AU2015313827C1/en active Active
-
2018
- 2018-02-27 AU AU2018201410A patent/AU2018201410A1/en not_active Abandoned
-
2021
- 2021-05-25 JP JP2021087382A patent/JP7288927B2/ja active Active
-
2022
- 2022-02-15 US US17/672,242 patent/US20220313818A1/en active Pending
-
2023
- 2023-05-29 JP JP2023087736A patent/JP7591092B2/ja active Active
-
2024
- 2024-11-15 JP JP2024199491A patent/JP2025024104A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6877357B2 (ja) | Ｇｄｆ８阻害剤を用いて、強度及び機能を増加させる方法 | |
| JP2026032035A (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| JP7581399B2 (ja) | ブドウ膜炎および黄斑浮腫の処置のためのｉｌ６ｒ抗体を含む組成物およびそれを使用する方法 | |
| JP2017031213A5 (enExample) | ||
| AU2021240290A1 (en) | Methods of treating non-radiographic axial spondyloarthritis using interleukin-17 (IL-17) Antagonists | |
| CN108310376A (zh) | 用于治疗类风湿性关节炎的组合物及其使用方法 | |
| RU2013125775A (ru) | Способы лечения ревматоидного артрита с применением антагонистов il-17 | |
| US20220313818A1 (en) | Use of il-17 antagonists to inhibit the progression of structural damage in psoriatic arthritic patients | |
| JP7630012B2 (ja) | Ｉｌ－６ｒアンタゴニストを投与することによってリウマチ性多発筋痛症を処置するための組成物および方法 | |
| JP2025530983A (ja) | 二重特異性抗ｐｓｍａ×抗ｃｄ２８抗体を抗ｐｄ－１抗体と組み合わせて、転移性去勢抵抗性前立腺癌を治療する方法 | |
| CN115667301A (zh) | 治疗具有类风湿性关节炎的受试者的疼痛的组合物和方法 | |
| Morel | Infection prevention and vaccination in the rheumatic diseases | |
| EP4688142A1 (en) | Methods for treating eosinophilic gastroenteritis by administering an il-4r antagonist | |
| JP2020517648A5 (enExample) | ||
| NZ761478A (en) | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |